Molnupiravir, Effective against Omicron?? FDA Panel Recommends Merck COVID Pill, Despite “More Questions Than Answers”
A U.S. Food and Drug Administration advisory panel on Tuesday voted narrowly to recommend Emergency Use Authorization of Merck’s five-day pill to treat COVID, despite the panel expressing a host of concerns about the drug’s safety and efficacy. The U.S.
Read More